Clinical Trial Update: CYPRESS - CYPHER for Evaluating Sustained Safety [Phase 4]

View source ↗

Summary

Phase 4 trial update examining the Cypher sirolimus-eluting coronary stent for sustained safety in coronary artery disease; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher Sirolimus-Eluting Coronary Stent System (sirolimus-eluting coronary stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN | Results posted: 2013-10-09